Drawing for ONE DMI PLUS

USPTO serial 98820699

ONE DMI PLUS

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
Examiner
FLINT, DANIEL LEE
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with ONE DMI PLUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $449*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Eric T. Fingerhut

Eric T. Fingerhut Dykema Gossett PLLC1301 K Street, NWSuite 1100 WestWashington, DC 20005

Goods and services

ClassDescriptionStatusFirst use
009Software as a Medical Device (SaMD), downloadable, for analyzing diagnostic biomarkers in patient blood, urine, and saliva for use in measuring, screening and monitoring patient vital signs, oral and systemic health, and social habits related to health; Software as a Medical Device (SaMD), downloadable, for analyzing patient blood, urine, and saliva for use in measuring, screening and monitoring patient vital signs, oral, dental, cardiovascular, metabolic, and inflammatory diseases and conditions, mental health and social habits related to health, markers associated with oral, dental, cardiovascular, metabolic, and inflammatory diseases and conditions, mental health and social habits related to health, blood panels including but not limited to HbA1C, lipid panels, glucose, uric acid and inflammation panels, and oral fluid panels including salivary markersACTIVE
010Medical apparatus for detecting biomarkers in patient blood, urine, and saliva for use in measuring, screening and monitoring patient vital signs, oral and systemic health, and social habits related to health; Medical apparatus for detecting biomarkers in patient blood, urine, and saliva for use in measuring, screening and monitoring patient vital signs, oral and systemic health, and social habits related to health, with integrated recorded software for monitoring oral and systemic health by analyzing biomarkers in patient blood, urine and saliva, sold as a unit; Medical devices for analyzing patient blood, urine, and saliva for use in measuring, screening and monitoring patient vital signs, oral, dental, cardiovascular, metabolic, and inflammatory diseases and conditions, mental health and social habits related to health, markers associated with oral, dental, cardiovascular, metabolic, and inflammatory diseases and conditions, mental health and social habits related to health, blood panels including but not limited to HbA1C, lipid panels, glucose, uric acid and inflammation panels, and oral fluid panels including salivary markers, with embedded software for monitoring oral and systemic health by analyzing biomarkers in patient blood, urine and salivaACTIVE
042Software as a service (SAAS) services featuring software for measuring, screening and monitoring patient vital signs, various disease markers, social health markers, and oral and systemic health using blood, urinary and salivary analysisACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 25, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 24, 2026EX1GSOU EXTENSION 1 GRANTED
Jul 24, 2026EXT1SOU EXTENSION 1 FILED
Jul 24, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 27, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 2, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 2, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 26, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 1, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 26, 2025XAECEXAMINER'S AMENDMENT ENTERED
Oct 26, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 26, 2025GNEAEXAMINERS AMENDMENT E-MAILED
Oct 26, 2025CNEAEXAMINERS AMENDMENT -WRITTEN
Aug 10, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 10, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 10, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 14, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 14, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 14, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 28, 2025DOCKASSIGNED TO EXAMINER
Apr 24, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 25, 2024NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance